The lymphocytotoxic crossmatch in liver transplantation: a clinicopathologic analysis.
作者信息
Nakamura K, Yagihashi A, Iwaki Y, Takaya S, Hartman G G, Murase N, Bronsther O, Manez R, Fung J J, Iwatsuki S
机构信息
Pittsburgh Transplant Institute, Department of Pathology, Pennsylvania.
出版信息
Transplant Proc. 1991 Dec;23(6):3021-2.
Abstract
摘要
相似文献
1
The lymphocytotoxic crossmatch in liver transplantation: a clinicopathologic analysis.肝移植中的淋巴细胞毒性交叉配型：一项临床病理分析
Transplant Proc. 1991 Dec;23(6):3021-2.
2
Positive lymphocytotoxic crossmatch does not adversely affect survival in living donor liver transplantation.淋巴细胞毒交叉配合试验阳性并不会对活体肝移植受者的生存造成不良影响。
Dig Surg. 2009 Feb;26(6):482-6. doi: 10.1159/000253873. Epub 2010 Jan 8.
3
4
Orthotopic liver-small bowel transplantation in pigs: study of immunologic parameters during therapy with FK 506-based immunosuppressive regimens.
Transplant Proc. 1996 Oct;28(5):2471-3.
5
Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation.T淋巴细胞毒性交叉配型在肝移植及肝肾联合移植中的意义
Transplantation. 2001 Apr 27;71(8):1163-8. doi: 10.1097/00007890-200104270-00025.
6
Posttransplant donor-specific T-lymphocytotoxic antibody in liver transplant patients with a positive crossmatch.交叉配型阳性的肝移植患者移植后供体特异性T淋巴细胞毒性抗体
Transplant Proc. 1992 Dec;24(6):2510-1.
7
Positive T lymphocytotoxic cross-match in living donor liver transplantation.
Liver Transpl. 2003 Oct;9(10):1062-6. doi: 10.1053/jlts.2003.50209.
8
Impact of immunosuppression in liver transplantation across a positive crossmatch.免疫抑制在阳性交叉配型肝移植中的影响。
Transplant Proc. 1998 Jun;30(4):1466-7. doi: 10.1016/s0041-1345(98)00318-2.
9
10
Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy.在环孢素或FK 506治疗下原发性人肝同种异体移植中的阳性交叉配型
Transplant Proc. 1991 Feb;23(1 Pt 1):396-9.
引用本文的文献
1
Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.肝移植中供者特异性人类白细胞抗原抗体的临床意义
World J Gastroenterol. 2015 Oct 21;21(39):11016-26. doi: 10.3748/wjg.v21.i39.11016.
2
Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss.抗体介导的排斥反应是导致先前不明原因的早期肝移植失败的一个因素。
Liver Transpl. 2014 Feb;20(2):218-27. doi: 10.1002/lt.23788. Epub 2014 Jan 2.
3
Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.他克莫司。其药理学及在肝移植和肾移植中的治疗潜力综述。
Drugs. 1993 Oct;46(4):746-94. doi: 10.2165/00003495-199346040-00009.
4
Posttransplant donor-specific T-lymphocytotoxic antibody in liver transplant patients with a positive crossmatch.交叉配型阳性的肝移植患者移植后供体特异性T淋巴细胞毒性抗体
Transplant Proc. 1992 Dec;24(6):2510-1.
本文引用的文献
1
2
Signs of hyperacute rejection of liver grafts in rhesus monkeys after donor-specific presensitization.
Transplant Proc. 1987 Feb;19(1 Pt 2):1082-3.
3
4
Immunopathology of liver transplantation.
Crit Rev Immunol. 1989;9(2):67-92.
5
Extended preservation of human liver grafts with UW solution.用UW液延长人肝移植供肝的保存时间。
JAMA. 1989 Feb 3;261(5):711-4.
6
FK 506 for liver, kidney, and pancreas transplantation.用于肝脏、肾脏和胰腺移植的FK 506。
Lancet. 1989 Oct 28;2(8670):1000-4. doi: 10.1016/s0140-6736(89)91014-3.
7
Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy.在环孢素或FK 506治疗下原发性人肝同种异体移植中的阳性交叉配型
Transplant Proc. 1991 Feb;23(1 Pt 1):396-9.
Zotero 插件